Concordance between transbronchial lung cryobiopsy and surgical lung biopsy for interstitial lung disease in the same patients.
Confidence level
Cryobiopsy
Idiopathic pulmonary fibrosis
Interstitial pneumonia
Multidisciplinary discussion
Journal
BMC pulmonary medicine
ISSN: 1471-2466
Titre abrégé: BMC Pulm Med
Pays: England
ID NLM: 100968563
Informations de publication
Date de publication:
29 Jul 2023
29 Jul 2023
Historique:
received:
26
02
2023
accepted:
19
07
2023
medline:
31
7
2023
pubmed:
29
7
2023
entrez:
28
7
2023
Statut:
epublish
Résumé
The diagnostic accuracy and safety of transbronchial lung cryobiopsy (TBLC) via a flexible bronchoscope under sedation compared with that of surgical lung biopsy (SLB) in the same patients is unknown. Retrospectively the data of fifty-two patients with interstitial lung diseases (median age: 63.5 years; 21 auto-antibody positive) who underwent TBLC followed by SLB (median time from TBLC to SLB: 57 days) was collected. The samples from TBLC and SLB were randomly labelled to mask the relationship between the two samples. Diagnosis was made independently by pathologists, radiologists, and pulmonary physicians in a stepwise manner, and a final diagnosis was made at multidisciplinary discussion (MDD). In each diagnostic step the specific diagnosis, the diagnostic confidence level, idiopathic pulmonary fibrosis (IPF) diagnostic guideline criteria, and treatment strategy were recorded. Without clinical and radiological information, the agreement between the histological diagnoses by TBLC and SLB was 42.3% (kappa [κ] = 0.23, 95% confidence interval [CI]: 0.08-0.39). However, the agreement between the TBLC-MDD and SLB-MDD diagnoses and IPF/non-IPF diagnosis using the two biopsy methods was 65.4% (κ = 0.57, 95% CI: 0.42-0.73) and 90.4% (47/52), respectively. Out of 38 (73.1%) cases diagnosed with high or definite confidence at TBLC-MDD, 29 had concordant SLB-MDD diagnoses (agreement: 76.3%, κ = 0.71, 95% CI: 0.55-0.87), and the agreement for IPF/non-IPF diagnoses was 97.4% (37/38). By adding the pathological diagnosis, the inter-observer agreement of clinical diagnosis improved from κ = 0.22 to κ = 0.42 for TBLC and from κ = 0.27 to κ = 0.38 for SLB, and the prevalence of high or definite diagnostic confidence improved from 23.0% to 73.0% and from 17.3% to 73.0%, respectively. Of all 383 TBLC performed during the same period, pneumothorax occurred in 5.0% of cases, and no severe bleeding, acute exacerbation of interstitial lung disease, or fatal event was observed. TBLC via a flexible bronchoscope under deep sedation is safely performed, and the TBLC-MDD diagnosis with a high or definite confidence level is concordant with the SLB-MDD diagnosis in the same patients.
Sections du résumé
BACKGROUND
BACKGROUND
The diagnostic accuracy and safety of transbronchial lung cryobiopsy (TBLC) via a flexible bronchoscope under sedation compared with that of surgical lung biopsy (SLB) in the same patients is unknown.
METHODS
METHODS
Retrospectively the data of fifty-two patients with interstitial lung diseases (median age: 63.5 years; 21 auto-antibody positive) who underwent TBLC followed by SLB (median time from TBLC to SLB: 57 days) was collected. The samples from TBLC and SLB were randomly labelled to mask the relationship between the two samples. Diagnosis was made independently by pathologists, radiologists, and pulmonary physicians in a stepwise manner, and a final diagnosis was made at multidisciplinary discussion (MDD). In each diagnostic step the specific diagnosis, the diagnostic confidence level, idiopathic pulmonary fibrosis (IPF) diagnostic guideline criteria, and treatment strategy were recorded.
RESULTS
RESULTS
Without clinical and radiological information, the agreement between the histological diagnoses by TBLC and SLB was 42.3% (kappa [κ] = 0.23, 95% confidence interval [CI]: 0.08-0.39). However, the agreement between the TBLC-MDD and SLB-MDD diagnoses and IPF/non-IPF diagnosis using the two biopsy methods was 65.4% (κ = 0.57, 95% CI: 0.42-0.73) and 90.4% (47/52), respectively. Out of 38 (73.1%) cases diagnosed with high or definite confidence at TBLC-MDD, 29 had concordant SLB-MDD diagnoses (agreement: 76.3%, κ = 0.71, 95% CI: 0.55-0.87), and the agreement for IPF/non-IPF diagnoses was 97.4% (37/38). By adding the pathological diagnosis, the inter-observer agreement of clinical diagnosis improved from κ = 0.22 to κ = 0.42 for TBLC and from κ = 0.27 to κ = 0.38 for SLB, and the prevalence of high or definite diagnostic confidence improved from 23.0% to 73.0% and from 17.3% to 73.0%, respectively. Of all 383 TBLC performed during the same period, pneumothorax occurred in 5.0% of cases, and no severe bleeding, acute exacerbation of interstitial lung disease, or fatal event was observed.
CONCLUSIONS
CONCLUSIONS
TBLC via a flexible bronchoscope under deep sedation is safely performed, and the TBLC-MDD diagnosis with a high or definite confidence level is concordant with the SLB-MDD diagnosis in the same patients.
Identifiants
pubmed: 37507693
doi: 10.1186/s12890-023-02571-9
pii: 10.1186/s12890-023-02571-9
pmc: PMC10385958
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
279Informations de copyright
© 2023. The Author(s).
Références
Lancet Respir Med. 2020 Feb;8(2):171-181
pubmed: 31578168
Eur Respir J. 2020 Dec 10;56(6):
pubmed: 32817003
Am J Respir Crit Care Med. 2004 Oct 15;170(8):904-10
pubmed: 15256390
Respirology. 2014 Aug;19(6):900-6
pubmed: 24890124
Lancet Respir Med. 2016 Jul;4(7):557-565
pubmed: 27180021
Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824
pubmed: 21471066
Am J Respir Crit Care Med. 2016 May 15;193(10):1161-7
pubmed: 26646481
Eur Respir J. 2013 Sep;42(3):750-7
pubmed: 23222877
Am J Respir Crit Care Med. 2016 Apr 1;193(7):745-52
pubmed: 26562389
J Thorac Dis. 2017 Jul;9(7):2186-2203
pubmed: 28840020
Respiration. 2022;101(4):394-400
pubmed: 34784603
Am J Respir Crit Care Med. 2019 May 15;199(10):1249-1256
pubmed: 30864813
Am J Respir Crit Care Med. 2001 Nov 1;164(9):1722-7
pubmed: 11719316
Respir Res. 2020 Sep 4;21(1):231
pubmed: 32887582
Thorax. 2004 Jun;59(6):500-5
pubmed: 15170033
Am J Respir Crit Care Med. 2022 May 1;205(9):e18-e47
pubmed: 35486072
Am J Respir Crit Care Med. 2021 May 15;203(10):1306-1313
pubmed: 33285079
Chest. 1981 Mar;79(3):316-21
pubmed: 7471862
Respiration. 2017;93(4):285-292
pubmed: 28245447
Eur Respir J. 2015 Oct;46(4):976-87
pubmed: 26160873
Am J Respir Crit Care Med. 2018 Sep 1;198(5):e44-e68
pubmed: 30168753
Respiration. 2016;91(3):215-27
pubmed: 26926876
Chest. 2020 Apr;157(4):1030-1042
pubmed: 31783014
Am J Respir Crit Care Med. 2013 Sep 15;188(6):733-48
pubmed: 24032382
Lancet Respir Med. 2018 Feb;6(2):138-153
pubmed: 29154106